The study demonstrates how generative deep learning, when combined with structural prediction and affinity modeling, can ...

Last year, Belgium’s ExeVir Bio raised 23 million euros ($27 million) to finance development of llama antibodies – and now it is ready to begin clinical development of a potential treatment ...

Belgium’s ExeVir Bio is to accelerate development of a new treatment for COVID-19 based on llama antibodies, after a 23 million euro ($27 million) financing round. ExeVir is a spin-out of Vlaams ...

We recently compiled a list of the 12 Best Growth Stocks to Buy and Hold for the Long Term. In this article, we are going to take a look at where argenx SE (NASDAQ:ARGX) stands against the other ...

Penpulimab-kcqx is a differentiated PD-1 monoclonal antibody developed independently ... HPE Enabled ‘Space Llama’ AI Program On Board The ISS For updates and corrections, email newsroom ...

The company sets itself apart from its competitors by the use of its proprietary Simple Antibody discovery platform, which leverages unique characteristics of the llama immune system to create ...

Their goal was to create a more powerful antibody treatment against influenza A, one of the most common and deadly strains of the virus. What they discovered could change how people are protected ...

At its inaugural LlamaCon AI developer conference on Tuesday, Meta announced an API for its Llama series of AI models: the Llama API. Available in limited preview, the Llama API lets developers ...

Meta is releasing a new tool it hopes will encourage developers to use its family of Llama models for their next project. At its inaugural LlamaCon event in Menlo Park on Tuesday, the company ...

Meta Platforms Inc. is likely to delay the release of its upcoming Llama 4 Behemoth artificial intelligence model, in a move that could have serious implications for the broader AI industry.